Scholar : Pediatric Hematology and Oncology, Volume 34, Issue 5, August 2017 is now available online on Taylor & Francis Online

The online platform for Taylor & Francis Online content Pediatric Hematology and Oncology, Volume 34, Issue 5, August 2017 is now available online on Taylor & Francis Online. This new issue contains the following articles: Global Hematology/Oncology and Clinical Practice Identifying opportunities to bridge disparity gaps in curing childhood cancer in Malawi: Malignancies with excellent curative potential account for the majority of diagnoses Nader Kim El-Mallawany MD, Peter Wasswa MBChB, Idah Mtete CO, Mercy Mutai CO, Christopher C. Stanley MS, Mary Mtunda NMT, Mary Chasela NMT, Atupele Mpasa MBChB, Stella Wachepa MBChB, William Kamiyango CO, Jimmy Villiera CO, Peter N. Kazembe MBChB & Parth S. Mehta MD, MPH Pages: 261-274 | DOI: 10.1080/08880018.2017.1395934 Leukemia, Lymphoma and Histiocytoses Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients Salah Aref, Emad Azmy, Kadry El-bakry, Lobna Ibrahim & Sherin Abdel Aziz Pages: 275-285 | DOI: 10.1080/08880018.2017.1363836 Non-Malignant Hematology Wiskott–Aldrich syndrome: Two case reports with a novel mutation Karaman Kamuran, Mecnun Çetin, Hadi Geylan, Serap Karaman, Nihat Demir, Eyyup Yurekturk, İbrahim Yavuz, Göknur Yavuz & Oğuz Tuncer Pages: 286-291 | DOI: 10.1080/08880018.2017.1397072 Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: A contemporary issue Mehran Karimi MD, Fatemeh Amirmoezi MD, Sezaneh Haghpanah MD, MPH, Seyedpouria Ostad MD, Mehrzad Lotfi MD, Sepideh Sefidbakht MD & Shahed Rezaian MD Pages: 292-297 | DOI: 10.1080/08880018.2017.1400135 The effect of anti-thyroid antibodies positivity on children with primary immune thrombocytopenia Suzan O. Mousa MD, Gamal T. Soliman MD, Ahmed A.-F. Saedii MD & Emad N. Hameed MBBCh Pages: 298-307 | DOI: 10.1080/08880018.2017.1400136 Solid Tumors and Neurooncology Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma Frank Berthold MD, Marc Hömberg MD, Inna Proleskovskaya MD, Pavel Mazanek MD, Margarita Belogurova MD, Angela Ernst MSc & Jaroslav Sterba MD Pages: 308-319 | DOI: 10.1080/08880018.2017.1373314 Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States Diarmuid Coughlan, Matthew Gianferante, Charles F Lynch, Jennifer L Stevens & Linda C Harlan Pages: 320-330 | DOI: 10.1080/08880018.2017.1373315 Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma Sarah B. Whittle MD, MS, Kaitlin C. Williamson MD & Heidi V. Russell MD, PhD Pages: 331-342 | DOI: 10.1080/08880018.2017.1396386 Pediatric GIST presenting as anemia Paola Cianci MD, Chiara Luini MD, Maddalena Marinoni MD, Luigi Nespoli MD, Alessandro Salvatoni MD & Silvia Salvatore MD, PhD Pages: 343-347 | DOI: 10.1080/08880018.2017.1396387 To update which email alerts you receive, manage your alerts within the My Account area. You can also unsubscribe from this alert with one click. If you need any further help, please contact us at support@tandfonline.com Please do not reply to this email. To ensure that you receive your alerts and information from Taylor & Francis Online, please add "alerts@tandfonline.com" and "info@tandfonline.com" to your safe senders list. Taylor & Francis, an Informa business. Taylor & Francis is a trading name of Informa UK Limited, registered in England under no. 1072954. Registered office: 5 Howick Place, London, SW1P 1WG.